AllBright Law Offices supports clients with a comprehensive range of corporate and M&A matters, including cross-border transactions, asset restructuring for listed companies, mixed ownership reform of state-owned enterprises, and corporate governance. Fangzhou Bao leads the practice from the Shanghai office, which also hosts Zhengchun Yu, particularly experienced in the pharmaceutical and medical sectors, and Luoyan Xu, who primarily serves private enterprises. In Qingdao, Rui Wang offers expertise in the acquisition of listed companies, acquisitions by state-owned enterprises, and private equity investments, covering sectors such as new energy, petrochemical, and real estate.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • Ziyang Lianyao Medical Devices Co., Ltd.
  • Jiang Pharmaceutical Group Co., Ltd
  • Hefei Cubic Pharmaceutical Co Ltd
  • Beijing Shurui Robot Co Ltd
  • Jiangsu New Element Medicine Technology Co., Ltd.
  • Gracell Biot echnologies Inc.
  • Shenzhen Yantian Port Logistics Co., Ltd.
  • Gongqingcheng Shengbang Cami Investment Partnership (Limited Partnership)
  • Zheng Xu, Anhui Xunshun Investment Partnership (Limited Partnership)

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Fangzhou Bao

Praxisleitung

Fangzhou Bao

Weitere Kernanwält*innen

Zhengchun Yu; Congjun Wen; Chunyan Zhu; Luoyan Xu; Rui Wang; Bin (Jordan) Yang